Clinical Efficacy and Safety of Combined House Dust mite Subcutaneous Immunotherapy and Omalizumab in Five Cases of Allergic Rhinitis and Asthma
Allergen immunotherapy (AIT) is a well-recognized treatment for altering the natural course of respiratory allergy which builds immune tolerance and prevents progression of allergic diseases. In our five cases of house dust mite (HDM)-driven allergic rhinitis and asthma, combined HDM Subcutaneous Im...
Saved in:
| Main Authors: | P.C. Kathuria, Manisha Rai |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2021-07-01
|
| Series: | Indian Journal of Medical Specialities |
| Subjects: | |
| Online Access: | https://journals.lww.com/10.4103/injms.injms_7_21 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
House Dust Mite Species in Ordu, Turkey
by: Rana Akyazı, et al.
Published: (2019-12-01) -
House dust mite allergy – Management
by: P. C. Kathuria, et al.
Published: (2024-12-01) -
Effect of house dust mite sublingual immunotherapy in patients with adult atopic dermatitis with rhinitis
by: Mayuko Mizuno, et al.
Published: (2024-12-01) -
Characterization and cross-reactivity assessment of group-29 allergens originating from Dermatophagoides pteronyssinus, Dermatophagoides farinae, and Tyrophagus putrescentiae
by: Jinni Chen, et al.
Published: (2025-04-01) -
Stage-specific transcriptomic analysis reveals insights into the development, reproduction and biological function of allergens in the European house dust mite Dermatophagoides pteronyssinus
by: José Cristian Vidal-Quist, et al.
Published: (2025-05-01)